Forefront Analytics, LLC
- SEC CIK
- 0001696802
- Latest filing
- Aug 12, 2026
Holdings changes from Q2 2022 to Q3 2022
Long positions only; new, added, reduced and sold out are based on share counts. Pick any two quarters this institution filed.
- New
- 4
- Est. +$701.0K
- Added
- 27
- Est. +$868.6K
- Reduced
- 26
- Est. −$3.01M
- Sold out
- 4
- Est. −$558.0K
Portfolio value went from $206.4M to $187.8M (−$18.7M (−9.0%)); positions from 66 to 66 (0).
All Q3 2022 holdingsAll Q2 2022 holdings
In the shares, value and % of portfolio columns, the top figure is Q3 2022 and the gray one below is Q2 2022. For stocks that split between the two quarters, Q2 2022 shares are converted at the split ratio before comparing.
| Security | Action | Shares | Share change | Value | Est. bought or sold | % of portfolio | Weight change (pp) |
|---|---|---|---|---|---|---|---|
| CDAKCodiak BioSciences, Inc. | AddedHistory | 56,48518,310 | +38,175+208.5% | $47.0K$57.0K | +$31.8K | <0.1%<0.1% | 0.00 |
| ORTXOrchard Therapeutics plc | AddedHistory | 100,04192,641 | +7,400+8.0% | $54.0K$58.0K | +$3.99K | <0.1%<0.1% | 0.00 |
| SURFSurface Oncology, Inc. | AddedHistory | 66,83841,688 | +25,150+60.3% | $70.0K$71.0K | +$26.3K | <0.1%<0.1% | 0.00 |
| CTMXCytomX Therapeutics, Inc. | AddedHistory | 47,86935,919 | +11,950+33.3% | $71.0K$67.0K | +$17.7K | <0.1%<0.1% | +0.01 |
| JSPRJasper Therapeutics, Inc. | AddedHistory | 119,80034,625 | +85,175+246.0% | $94.0K$69.0K | +$66.8K | 0.1%<0.1% | +0.02 |
| MREOMereo BioPharma Group plc | AddedHistory | 112,80075,850 | +36,950+48.7% | $96.0K$83.0K | +$31.4K | 0.1%<0.1% | +0.01 |
| State Street Energy Select Sector SPDR ETF81369Y506 | Added– | 3,6983,612 | +86+2.4% | $266.0K$258.0K | +$6.19K | 0.1%0.1% | +0.02 |
| NVDANVIDIA Corp | AddedHistory | 2,4422,246 | +196+8.7% | $297.0K$341.0K | +$23.8K | 0.2%0.2% | −0.01 |
| PFEPfizer Inc | AddedHistory | 7,5746,694 | +880+13.1% | $329.0K$348.0K | +$38.2K | 0.2%0.2% | +0.01 |
| JPMJPMorgan Chase & Co | AddedHistory | 3,3633,334 | +29+0.9% | $351.0K$375.0K | +$3.03K | 0.2%0.2% | +0.01 |
| DBAInvesco DB Agriculture Fund | AddedHistory | 19,48419,153 | +331+1.7% | $390.0K$390.0K | +$6.63K | 0.2%0.2% | +0.02 |
| SPDR Series Trust78468R622 | Added– | 5,1264,808 | +318+6.6% | $450.0K$435.0K | +$27.9K | 0.2%0.2% | +0.03 |
| ProShares Tr74347R842 | Added– | 16,79716,523 | +274+1.7% | $482.0K$511.0K | +$7.86K | 0.3%0.2% | +0.01 |
| SPDR Series Trust78468R200 | Added– | 16,36216,274 | +88+0.5% | $496.0K$490.0K | +$2.67K | 0.3%0.2% | +0.03 |
| iShares Tr46429B655 | Added– | 19,72919,641 | +88+0.4% | $992.0K$980.0K | +$4.42K | 0.5%0.5% | +0.05 |
| iShares Tips Bond ETF464287176 | Added– | 10,85010,592 | +258+2.4% | $1.14M$1.21M | +$27.0K | 0.6%0.6% | +0.02 |
| Vanguard Morningstar Small-Cap ETF922908751 | Added– | 11,20911,167 | +42+0.4% | $1.92M$1.97M | +$7.18K | 1.0%1.0% | +0.07 |
| iShares Tr464288588 | Added– | 21,86021,816 | +44+0.2% | $2.00M$2.13M | +$4.03K | 1.1%1.0% | +0.04 |
| Vanguard Total International Bond ETF92203J407 | Added– | 44,08443,996 | +88+0.2% | $2.10M$2.18M | +$4.20K | 1.1%1.1% | +0.07 |
| iShares Tr464288661 | Added– | 21,22321,132 | +91+0.4% | $2.43M$2.52M | +$10.4K | 1.3%1.2% | +0.07 |
| iShares Tr464287440 | Added– | 29,28929,232 | +57+0.2% | $2.81M$2.99M | +$5.47K | 1.5%1.4% | +0.05 |
| iShares Iboxx $ Investment Grade Corporate Bond ETF464287242 | Added– | 36,92036,663 | +257+0.7% | $3.79M$4.03M | +$26.4K | 2.0%2.0% | +0.06 |
| SPDR Series Trust78464A490 | Added– | 156,030151,984 | +4,046+2.7% | $6.24M$6.87M | +$161.8K | 3.3%3.3% | −0.01 |
| SPYSPDR S&P 500 ETF Trust | AddedHistory | 19,52519,459 | +66+0.3% | $6.97M$7.34M | +$23.6K | 3.7%3.6% | +0.16 |
| Vanguard Ftse Developed Markets ETF921943858 | Added– | 263,021262,208 | +813+0.3% | $9.56M$10.7M | +$29.6K | 5.1%5.2% | −0.09 |
| Vanguard Ftse Emerging Markets ETF922042858 | Added– | 267,767263,911 | +3,856+1.5% | $9.77M$11.0M | +$140.7K | 5.2%5.3% | −0.12 |
| PIMCO ETF Tr72201R304 | Added– | 205,507203,200 | +2,307+1.1% | $11.5M$13.2M | +$129.4K | 6.1%6.4% | −0.28 |
Estimated amounts multiply the change in shares by the quarter-end price implied by the filing (market value divided by shares): new positions use this quarter's value and sold-out positions last quarter's; positions reported only as principal (PRN) cannot be estimated. 13F shows only quarter-end holdings, not when trades happened or at what price.